Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
BACKGROUND The efficacy of ustekinumab, an antagonist of the p40 subunit of interleukin-12 and interleukin-23, as induction and maintenance therapy in patients with ulcerative c...